Orgenesis Inc.
orgenesis.comWhat Do They Do?
Provides cell-process development and hospital services, and develops decentralized production platforms for hospitals, research centers and healthcare institutions.
10-K for FY2024, filed Mar 26, 2026Our activity is based on partnerships with hospital, research centers and leading centers of excellence for the supply of products.…View ↗
Over the past year, we have focused on validating advanced production platforms for various cell types. These platforms are designed to…View ↗
Included in cell process development services is hospital supplies revenue, which is derived principally from the performance of services…View ↗
How Do They Make Money?
Customers pay for cell-process development and processing under contracts generally lasting a few months to one year, with average payment terms between thirty and one hundred and fifty days; hospitals pay when products and services are received. License fees are paid when milestones are confirmed and payment is certain.
10-K for FY2024, filed Mar 26, 2026The Company’s agreements are primarily service and processing contracts, the performance obligations of which range in duration from a few…View ↗
The Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company…View ↗
Revenue recognized under license fees are recognized upon the confirmation of licensee of milestones completed and certainty of payment of…View ↗
Revenue recognized under contracts for cell process development services may, in some contracts, represent multiple performance obligations…View ↗
Included in cell process development services is hospital supplies revenue, which is derived principally from the performance of services…View ↗
-
10-K for FY2024, filed Mar 26, 2026
FY2024 revenue by product or service ↗
$1M
-
10-K for FY2024, filed Mar 27, 2026
$1M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Cell Process Development Services And Hospital Services
|
99% |
Cell Process Development Services And Hospital Services, FY2024
$1M Sources
|
|
|
License Fees
Licensed
|
1.5% |
License Fees, FY2024
$15K Sources
|
Licensed |
Who Are Their Customers?
Partners with hospitals, research centers and centers of excellence to develop or adapt therapies and provide production platforms; its platforms target healthcare institutions and industry partners.
10-K for FY2024, filed Mar 26, 2026
Do Revenues Turn Into Profits?
No. It lost $48.2M in FY2024.
10-K for FY2024, filed Mar 27, 2026
−$39.8MView ↗
10-K for FY2024, filed Mar 27, 2026
−$48.2MView ↗
10-K for FY2024, filed Mar 27, 2026
−$17.3MView ↗
How Are They Changing?
Loading...
